As of 2025-11-07, the Relative Valuation of Arcus Biosciences Inc (RCUS) is (42.98) USD. This relative valuation is based on P/E multiples. With the latest stock price at 19.56 USD, the upside of Arcus Biosciences Inc based on Relative Valuation is -319.7%.
The range of the Relative Valuation is (34.50) - (48.89) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.3x - 17.5x | 15.4x |
| Forward P/E multiples | 12.2x - 19.1x | 15.3x |
| Fair Price | (34.50) - (48.89) | (42.98) |
| Upside | -276.4% - -349.9% | -319.7% |
| Date | P/E |
| 2025-11-05 | -6.80 |
| 2025-11-04 | -7.08 |
| 2025-11-03 | -7.27 |
| 2025-10-31 | -7.04 |
| 2025-10-30 | -7.21 |
| 2025-10-29 | -7.25 |
| 2025-10-28 | -7.10 |
| 2025-10-27 | -6.64 |
| 2025-10-24 | -6.18 |
| 2025-10-23 | -5.99 |
| 2025-10-22 | -6.00 |
| 2025-10-21 | -6.45 |
| 2025-10-20 | -6.24 |
| 2025-10-17 | -5.88 |
| 2025-10-16 | -5.93 |
| 2025-10-15 | -6.04 |
| 2025-10-14 | -5.58 |
| 2025-10-13 | -5.94 |
| 2025-10-10 | -5.21 |
| 2025-10-09 | -5.41 |
| 2025-10-08 | -5.38 |
| 2025-10-07 | -5.01 |
| 2025-10-06 | -5.17 |
| 2025-10-03 | -4.77 |
| 2025-10-02 | -4.78 |
| 2025-10-01 | -4.81 |
| 2025-09-30 | -4.86 |
| 2025-09-29 | -4.76 |
| 2025-09-26 | -4.59 |
| 2025-09-25 | -4.42 |
| 2025-09-24 | -4.47 |
| 2025-09-23 | -4.43 |
| 2025-09-22 | -4.47 |
| 2025-09-19 | -4.43 |
| 2025-09-18 | -4.44 |
| 2025-09-17 | -4.30 |
| 2025-09-16 | -4.20 |
| 2025-09-15 | -4.14 |
| 2025-09-12 | -4.11 |
| 2025-09-11 | -4.11 |
| 2025-09-10 | -4.19 |
| 2025-09-09 | -4.04 |
| 2025-09-08 | -4.09 |
| 2025-09-05 | -4.35 |
| 2025-09-04 | -4.13 |
| 2025-09-03 | -4.16 |
| 2025-09-02 | -3.86 |
| 2025-08-29 | -3.78 |
| 2025-08-28 | -3.79 |
| 2025-08-27 | -3.77 |